Bringing value to cancer research
This article argues for incorporating a broader definition of “value” into cancer clinical trials. Current trials primarily focus on efficacy and safety, neglecting patient-reported outcomes (PROs) such as quality of life, financial toxicity, and time burden, as well as cost-effectiveness. We propos...
Saved in:
| Main Authors: | Casey J. Allen, Horn M. Danea, Fabrice Smieliauskas, Stephen Edge, Rachel A. Greenup |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1580575/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
My Wellbeing Journal: Development of a communication and goal‐setting tool to improve care for older adults with chronic conditions and multimorbidity
by: Michael T. Lawless, et al.
Published: (2024-02-01) -
Medical Professionals' Treatment Decisions for Critical Patients With Ambiguous Treatment Wishes: A Cross‐Sectional Study
by: Kanako Yamamoto
Published: (2025-03-01) -
Co-designing a shared digital decision aid for HPV vaccination in French general practice
by: Dragos-Paul Hagiu, et al.
Published: (2025-07-01) -
Cost-effectiveness of contrast-enhanced breast MRI in suspicious mammographic microcalcifications
by: Barbara J. Fueger, et al.
Published: (2025-06-01) -
The dual role of empathy in clinical trial decisions
by: Mariam Chichua, et al.
Published: (2025-03-01)